Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

Hepatitis C virus (HCV) infects ∼2% of the world's population. It is estimated that there are more than 500,000 new infections annually in Egypt, the country with the highest HCV prevalence. An effective vaccine would help control this expanding global health burden. HCV is highly variable, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Giang, Erick, Dorner, Marcus, Prentoe, Jannick C., Dreux, Marlène, Evans, Matthew J., Bukh, Jens, Rice, Charles M., Ploss, Alexander, Burton, Dennis R., Law, Mansun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2012
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341081/
https://ncbi.nlm.nih.gov/pubmed/22492964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1114927109
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller